12/20
07:19 pm
plse
Pulse Biosciences (PLSE): Valuation Check After FDA IDE Approval for nPulse Cardiac Ablation Trial [Yahoo! Finance]
Low
Report
Pulse Biosciences (PLSE): Valuation Check After FDA IDE Approval for nPulse Cardiac Ablation Trial [Yahoo! Finance]
12/19
04:05 pm
plse
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/19
12:40 pm
plse
PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial [Yahoo! Finance]
Low
Report
PLSE Wins FDA IDE Approval to Launch nPulse AF Ablation Study Trial [Yahoo! Finance]
12/18
07:40 am
plse
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation [Yahoo! Finance]
Low
Report
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation [Yahoo! Finance]
12/18
07:00 am
plse
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
Low
Report
Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation
12/9
07:00 am
plse
Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology
Low
Report
Pulse Biosciences, Inc. Announces Initiation of Research Collaboration for the Treatment of Benign and Malignant Thyroid Tumors with nPulse™ Technology
11/21
04:05 pm
plse
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/6
04:05 pm
plse
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
Low
Report
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
11/6
12:10 am
plse
Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... [Yahoo! Finance]
Medium
Report
Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... [Yahoo! Finance]
11/5
11:06 pm
plse
Pulse Biosciences, Inc. (PLSE) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Pulse Biosciences, Inc. (PLSE) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/5
04:05 pm
plse
Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
Medium
Report
Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
10/24
07:00 am
plse
Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study
Low
Report
Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study
10/22
04:34 pm
plse
Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025 [Yahoo! Finance]
Low
Report
Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025 [Yahoo! Finance]
10/22
04:05 pm
plse
Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025
Low
Report
Pulse Biosciences Schedules Third Quarter 2025 Business Updates and Financial Results Conference Call for November 5, 2025
10/16
07:00 am
plse
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/11
08:20 pm
plse
Pulse Biosciences (PLSE): Assessing Valuation After Recent Share Price Swings [Yahoo! Finance]
Medium
Report
Pulse Biosciences (PLSE): Assessing Valuation After Recent Share Price Swings [Yahoo! Finance]
10/10
07:24 am
plse
Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting [Yahoo! Finance]
Medium
Report
Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting [Yahoo! Finance]
10/10
07:00 am
plse
Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
Medium
Report
Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
10/7
07:33 am
plse
Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting [Yahoo! Finance]
Low
Report
Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting [Yahoo! Finance]
10/7
07:00 am
plse
Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting
Low
Report
Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting